Conavi Medical Announces Grant of Stock Options

TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“Conavi Medical” or the “Company”) announced that its board of directors (the “Board”) has approved grants of stock options (the “Stock Options”) pursuant to the terms of the Omnibus Equity Incentive Plan effective January 2nd, 2025. A total of 1,073,685 Stock Options have been awarded to directors, officers, employees and consultants of the Company. The Stock Options are exercisable at a price of $0.70 CAD per share (being the closing price of the Company’s shares on the TSXV on January 2, 2025) for a period of 10 years from the date of the grant.

Read more at globenewswire.com